Is Asymmetric Dimethylarginine a Useful Biomarker in Children With Carbon Monoxide Poisoning?

Yazar A., Akin F., Sert A., Ture E., Topcu C., Yorulmaz A., ...More

PEDIATRIC EMERGENCY CARE, vol.35, no.3, pp.226-230, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.1097/pec.0000000000001758
  • Journal Name: PEDIATRIC EMERGENCY CARE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.226-230
  • Keywords: ADMA, biomarker, carbon monoxide, MYOCARDIAL DAMAGE, CARBOXYHEMOGLOBIN, ADMA, INTOXICATION, LACTATE, SEVERITY, OXYGEN
  • Karadeniz Technical University Affiliated: No

Abstract

Objective Carbon monoxide poisoning (COP) is the leading cause of mortality and morbidity due to poisoning worldwide. Because children are affected more quick and severely from COP, they may require a longer treatment period, even if carboxyhemoglobin (CO-Hb) and/or lactate levels return to normal. Therefore, a new marker that predicts the duration of treatment and the final outcomes of COP is needed.